Clinical Trial

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

Study acronym: RESTORE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-07
Trial Details
NCT Number NCT07135596
Lead Sponsor Tela Bio Inc
Conditions Breast Reconstruction
Enrollment 235 participants
Start Date 2026-04-10
Primary Completion 2030-06 (estimated)
Study Completion 2034-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-02